[Form 4] Arteris, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Arteris, Inc. (AIP) reporting person Nicholas B. Hawkins, Vice President and Chief Financial Officer, reported a sale of common stock on 09/09/2025 under a Rule 10b5-1 trading plan adopted June 4, 2025. The filing shows 3,660 shares were sold at a weighted average price of $8.6903, with the filing noting individual sale prices ranged from $8.51 to $8.83. After the reported sale, Mr. Hawkins beneficially owned 103,898 shares, held directly. The Form 4 was signed by an attorney-in-fact on 09/10/2025. The disclosure emphasizes the transaction was pursuant to a pre-established trading plan and offers to provide detailed per-price sale breakdowns upon request.

Positive

• Transaction executed under a 10b5-1 plan, indicating trades were pre-scheduled and compliant with insider trading rules
• Full disclosure of weighted average price and price range, and an offered willingness to provide per-price breakdowns on request

Negative

• Insider sale of 3,660 shares by the CFO reduces direct insider stock holdings
• No context provided on motive or use of proceeds; the filing contains only transactional details

Insights

Securities Analyst

TL;DR: Routine, pre-planned insider sale by the CFO; not clearly material to company fundamentals.

The reported sale of 3,660 shares under a 10b5-1 plan indicates the transactions were pre-scheduled, reducing the risk that this sale reflects new, undisclosed company-specific information. The size of the sale relative to the remaining beneficial ownership (103,898 shares) appears modest, suggesting limited direct impact on investor valuation. The filing is complete in disclosing price range and the plan adoption date, supporting transparency.

Corporate Governance Expert

TL;DR: Governance-compliant disclosure; the 10b5-1 plan demonstrates adherence to insider trading controls.

The Form 4 explicitly states the transactions were executed pursuant to a 10b5-1 trading plan adopted June 4, 2025, which is a governance best practice for scheduled insider trades. The report includes the weighted average price and acknowledges multiple executions within a specified range, with an offer to provide detail on per-price quantities. No amendments or other governance issues are evident from the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hawkins Nicholas B.

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CA 95008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP and Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2025		S(1)		3,660	D	$8.6903(2)	103,898	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on June 4, 2025.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $8.51 to $8.83 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for Hawkins Nicholas B.	09/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Arteris (AIP) insider Nicholas B. Hawkins report on Form 4?

The Form 4 reports that Nicholas B. Hawkins sold 3,660 shares of Arteris common stock on 09/09/2025 under a 10b5-1 trading plan.

At what price were the AIP shares sold by the CFO?

The filing lists a weighted average sale price of $8.6903, with individual sales ranging from $8.51 to $8.83.

How many AIP shares does the reporting person own after the transaction?

After the reported sale, the reporting person beneficially owned 103,898 shares.

Was the sale by the Arteris CFO part of a trading plan?

Yes. The sale was made pursuant to a 10b5-1 trading plan adopted on June 4, 2025.

Who signed the Form 4 for this transaction?

The Form 4 was signed by Paul Alpern, as Attorney-in-Fact for Nicholas B. Hawkins on 09/10/2025.